Gene · 2041
Papers3,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Insights into Lipid-Based Delivery Nanosystems of Protein-Tyrosine Kinase Inhibitors for Cancer Therapy. | Pharmaceutics | 2022 | 36559200 | PubTator, text mining | PubMed |
| Cooccurring Type 1 Diabetes Mellitus and Autoimmune Thyroiditis in a Girl with Craniofrontonasal Syndrome: Are EFNB1 Variants Associated with Autoimmunity? | Pharmaceuticals (Basel) | 2022 | 36558986 | PubTator, text mining | PubMed |
| Synthesis and Structural Optimization of 2,7,9-Trisubstituted purin-8-ones as FLT3-ITD Inhibitors. | Int J Mol Sci | 2022 | 36555810 | PubTator, text mining | PubMed |
| The Impact of Taste Preference-Related Gene Polymorphisms on Alcohol Consumption Behavior: A Systematic Review. | Int J Mol Sci | 2022 | 36555636 | PubTator, text mining | PubMed |
| Development of an In-House EphA2 ELISA for Human Serum and Measurement of Circulating Levels of EphA2 in Hypertensive Patients with Renal Dysfunction. | Diagnostics (Basel) | 2022 | 36553030 | PubTator, text mining | PubMed |
| PICALM and Alzheimer's Disease: An Update and Perspectives. | Cells | 2022 | 36552756 | PubTator, text mining | PubMed |
| Eph/Ephrin Promotes the Adhesion of Liver Tissue-Resident Macrophages to a Mimicked Surface of Liver Sinusoidal Endothelial Cells. | Biomedicines | 2022 | 36551990 | PubTator, text mining | PubMed |
| Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact. | Cancers (Basel) | 2022 | 36551730 | PubTator, text mining | PubMed |
| The impact of increasing levels of blood C-reactive protein on the inflammatory loci SPI1 and CD33 in Alzheimer's disease. | Transl Psychiatry | 2022 | 36550123 | PubTator, text mining | PubMed |
| Identification of a minimum number of genes to predict triple-negative breast cancer subgroups from gene expression profiles. | Hum Genomics | 2022 | 36536459 | PubTator, text mining | PubMed |
| Genomic, transcriptomic and RNA editing analysis of human MM1 and VV2 sporadic Creutzfeldt-Jakob disease. | Acta Neuropathol Commun | 2022 | 36517866 | PubTator, text mining | PubMed |
| Egfr signaling promotes juvenile hormone biosynthesis in the German cockroach. | BMC Biol | 2022 | 36514097 | PubTator, text mining | PubMed |
| Enhancing Cutaneous Wound Healing Based on Human Induced Neural Stem Cell-derived Exosomes. | Int J Nanomedicine | 2022 | 36506346 | PubTator, text mining | PubMed |
| EPH/Ephrin-Targeting Treatment in Breast Cancer: A New Chapter in Breast Cancer Therapy. | Int J Mol Sci | 2022 | 36499598 | PubTator, text mining | PubMed |
| An Overview of the Molecular Cues and Their Intracellular Signaling Shared by Cancer and the Nervous System: From Neurotransmitters to Synaptic Proteins, Anatomy of an All-Inclusive Cooperation. | Int J Mol Sci | 2022 | 36499024 | PubTator, text mining | PubMed |
| Preparation and Taste Profiling of the Enzymatic Protein Hydrolysate from a by-Product of Red Snow Crab Processing as a Natural Seasoning Compound. | Foods | 2022 | 36496720 | PubTator, text mining | PubMed |
| Complexity of progranulin mechanisms of action in mesothelioma. | J Exp Clin Cancer Res | 2022 | 36471440 | PubTator, text mining | PubMed |
| Cellular interactions in the pituitary stem cell niche. | Cell Mol Life Sci | 2022 | 36451046 | PubTator, text mining | PubMed |
| Identification of a naturally-occurring canine model for early detection and intervention research in high grade urothelial carcinoma. | Front Oncol | 2022 | 36439482 | PubTator, text mining | PubMed |
| Biological and disease hallmarks of Alzheimer's disease defined by Alzheimer's disease genes. | Front Aging Neurosci | 2022 | 36437990 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2041/papers?page=18